Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (361-370 of 508) with videos related to

Pageof 51
Sort By:
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Kardiologia Polska|December 20, 2014
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Pageof 51

Showing results (361-370 of 508) with videos related to

Sort By:
Pageof 51
European Heart Journal|July 16, 2021
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialNick Curzen, Zoe Nicholas, Beth Stuart, et al.
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Kardiologia Polska|December 20, 2014
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
Journal of the American College of Cardiology|October 23, 2024
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart FailureJohn G F Cleland, Pierpaolo Pellicori, Fraser J Graham, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Pageof 51